ARCHIVES

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | March 17, 2000

Download PDF Visit The Full Archive

Related Articles

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

Outcome Of Prostate Cancer Surgery Depends On Experience Of Surgeon

August 31, 2007